Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

232 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase I Clinical Trial of the Phosphatidylserine-targeting Antibody Bavituximab in Combination With Radiation Therapy and Capecitabine in the Preoperative Treatment of Rectal Adenocarcinoma.
Meyer J, Arriaga Y, Anandam J, Karri S, Syed S, Verma U, Abdelnaby A, Raja G, Dong Y, Beg MS, Balch G. Meyer J, et al. Among authors: verma u. Am J Clin Oncol. 2018 Oct;41(10):972-976. doi: 10.1097/COC.0000000000000401. Am J Clin Oncol. 2018. PMID: 28763330 Clinical Trial.
Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the In Vitro Integrity of T Cells from Cancer Patients.
Kobayashi M, Chung JS, Beg M, Arriaga Y, Verma U, Courtney K, Mansour J, Haley B, Khan S, Horiuchi Y, Ramani V, Harker D, Gopal P, Araghizadeh F, Cruz PD Jr, Ariizumi K. Kobayashi M, et al. Among authors: verma u. Clin Cancer Res. 2019 Jan 15;25(2):828-838. doi: 10.1158/1078-0432.CCR-18-0330. Epub 2018 Jul 26. Clin Cancer Res. 2019. PMID: 30049749 Free PMC article.
Disparities in Characteristics, Access to Care, and Oncologic Outcomes in Young-Onset Colorectal Cancer at a Safety-Net Hospital.
Fangman BD, Goksu SY, Chowattukunnel N, Beg MS, Sanford NN, Sanjeevaiah A, Cox J, Folkert MR, Aguilera TA, Mathews J, Pogacnik JS, Khatri G, Olson C, Polanco PM, Verma U, Hsiehchen D, Jones A, Kainthla R, Kazmi SM. Fangman BD, et al. Among authors: verma u. JCO Oncol Pract. 2021 May;17(5):e614-e622. doi: 10.1200/OP.20.00777. Epub 2021 Jan 11. JCO Oncol Pract. 2021. PMID: 33428470 Free PMC article.
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study.
Van Cutsem E, Martinelli E, Cascinu S, Sobrero A, Banzi M, Seitz JF, Barone C, Ychou M, Peeters M, Brenner B, Hofheinz RD, Maiello E, André T, Spallanzani A, Garcia-Carbonero R, Arriaga YE, Verma U, Grothey A, Kappeler C, Miriyala A, Kalmus J, Falcone A, Zaniboni A. Van Cutsem E, et al. Among authors: verma u. Oncologist. 2019 Feb;24(2):185-192. doi: 10.1634/theoncologist.2018-0072. Epub 2018 Sep 6. Oncologist. 2019. PMID: 30190299 Free PMC article. Clinical Trial.
232 results